STX1B and cancer: In particular, Shiga toxin 1 B-subunit (Stx1B) has been coupled to several chemotherapeutic compounds for targeting tumors, with excellent outcomes in intracellular transport of such drugs and elimination of cancer cells [18, 19, 44–46].